4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 885.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,500.00
  • 52 Week Low: 881.50
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 135
  • Market Cap: £137.52m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
87.46% above the market average87.46% above the market average87.46% above the market average87.46% above the market average87.46% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
93.91% above the market average93.91% above the market average93.91% above the market average93.91% above the market average93.91% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Price Book Ratio
80.5% below the market average80.5% below the market average80.5% below the market average80.5% below the market average80.5% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
56.18% below the market average56.18% below the market average56.18% below the market average56.18% below the market average56.18% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Price Chg 3m
79.02% below the market average79.02% below the market average79.02% below the market average79.02% below the market average79.02% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
47.34% below the market average47.34% below the market average47.34% below the market average47.34% below the market average47.34% below the market average
46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average
Momentum 20
92.31% below the market average92.31% below the market average92.31% below the market average92.31% below the market average92.31% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
94.53% below the market average94.53% below the market average94.53% below the market average94.53% below the market average94.53% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
54.43% below the market average54.43% below the market average54.43% below the market average54.43% below the market average54.43% below the market average
19.05% below the sector average19.05% below the sector average19.05% below the sector average19.05% below the sector average19.05% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
82.1% below the market average82.1% below the market average82.1% below the market average82.1% below the market average82.1% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Operating Profit Loss
85.35% below the market average85.35% below the market average85.35% below the market average85.35% below the market average85.35% below the market average
61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
9.13% above the market average9.13% above the market average9.13% above the market average9.13% above the market average9.13% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Cash
46.01% above the market average46.01% above the market average46.01% above the market average46.01% above the market average46.01% above the market average
65.85% above the sector average65.85% above the sector average65.85% above the sector average65.85% above the sector average65.85% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
19.00% above the market average19.00% above the market average19.00% above the market average19.00% above the market average19.00% above the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Buys 1y
71.33% above the market average71.33% above the market average71.33% above the market average71.33% above the market average71.33% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 885.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,500.00
52 Week Low 881.50
Volume 135
Shares Issued 15.54m
Market Cap £137.52m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 22-Aug-2025

Time Volume / Share Price
14:18 113 @ 881.50p
08:05 22 @ 881.50p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page